Company Market News

Centessa Pharmaceuticals plc (NASDAQ: CNTA)
8:00 PM UTC, 06/20/25
Last: $12.43 Change: -0.25 %Change: -1.97% Volume: 1,612,616
Morgan Stanley Upgrades Centessa Pharmaceuticals to Overweight From Equalweight, Adjusts PT to $26 From $11

Back

Last updated: 09/20/2024 5:39:28 AM

05:39 AM EDT, 09/20/2024 (MT Newswires) -- Centessa Pharmaceuticals (CNTA) has an average rating of buy and price targets ranging from $19 to $35, according to analysts polled by Capital IQ.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.




Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.